ask="24.75"
ask_size="200"
average_daily_volume="443218"
bid="16.14"
bid_size="5000"
book_value="8.12"
change="-0.55"
change_from_200_day_moving_average="-1.45"
change_from_50_day_moving_average="-1.33"
change_from_52_week_high="-5.66"
change_From_52_week_low="7.31"
change_in_percent="-2.83%"
close="18.91"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.29"
ebitda="-18.48M"
eps_estimate_current_year="-0.96"
eps_estimate_next_quarter="-0.20"
eps_estimate_next_year="-1.21"
ex_dividend_date="N/A"
float_shares="23627000"
high="19.68"
high_52_weeks="24.57"
last_trade_date="3/14/2017"
last_trade_price="18.91"
last_trade_size="17317"
last_trade_time="4:00pm"
low="18.88"
low_52_weeks="11.60"
market_capitalization="720.34M"
moving_average_200_day="20.36"
moving_average_50_day="20.24"
name="Retrophin
Inc."
notes="N/A"
one_year_target_price="33.33"
open="19.37"
pe_ratio="N/A"
peg_ratio="-1.01"
percent_change_from_200_day_moving_average="-7.10%"
percent_change_from_50_day_moving_average="-6.58%"
percent_change_from_52_week_high="-23.04%"
percent_change_from_52_week_low="+63.02%"
previous_close="19.46"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.40"
price_per_sales="5.55"
revenue="133.59M"
shares_outstanding="38093000"
short_ratio="16.58"
stock_exchange="NGM"
symbol="RTRX"
volume="257884"
weeks_range_52="11.60 - 24.57"
